0001225208-14-017932.txt : 20140805 0001225208-14-017932.hdr.sgml : 20140805 20140805095642 ACCESSION NUMBER: 0001225208-14-017932 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140804 FILED AS OF DATE: 20140805 DATE AS OF CHANGE: 20140805 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Merck & Co. Inc. CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MERCK DRIVE STREET 2: P.O. BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 BUSINESS PHONE: 908-423-1000 MAIL ADDRESS: STREET 1: ONE MERCK DRIVE STREET 2: P.O. BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 FORMER COMPANY: FORMER CONFORMED NAME: SCHERING PLOUGH CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AMBROSE ADELE D CENTRAL INDEX KEY: 0001182424 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06571 FILM NUMBER: 141014872 MAIL ADDRESS: STREET 1: 7277 164TH AVE NE STREET 2: BLDG 1 CITY: REDMOND STATE: WA ZIP: 98052 4 1 doc4.xml X0306 4 2014-08-04 0000310158 Merck & Co. Inc. MRK 0001182424 AMBROSE ADELE D ONE MERCK DRIVE WHITEHOUSE STATION NJ 08889-0100 1 Sr.V-P & Chief Comuns Officer Common Stock 2014-08-04 4 M 0 15000.0000 45.9800 A 34443.9080 D Common Stock 2014-08-04 4 M 0 8400.0000 44.3000 A 42843.9080 D Common Stock 2014-08-04 4 S 0 28669.0000 56.6368 D 14174.9080 D Stock Option (right to buy) 45.9800 2014-08-04 4 M 0 15000.0000 0.0000 D 2009-02-01 2018-01-31 Common Stock 15000.0000 0.0000 D Stock Option (right to buy) 44.3000 2014-08-04 4 M 0 8400.0000 0.0000 D 2009-02-28 2018-02-28 Common Stock 8400.0000 0.0000 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.5800 to $56.7100, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. Holdings include shares acquired in dividend reinvestment transactions. The option became exercisable in equal installments on 2/1/2009, 2/1/2010 and 2/1/2011. The option became exercisable in equal installments on 2/28/2009, 2/28/2010 and 2/28/2011. Katie Fedosz as Attorney-in-Fact for Adele D. Ambrose 2014-08-05